Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of putative actionable alterations in clinically relevant genes in breast cancer.

British journal of cancer - 1 Oct 2021

Kaur Pushpinder, Porras Tania B, Colombo Anthony, Ring Alexander, Lu Janice, Kang Irene, Lang Julie E

Abstract excerpt

BACKGROUND: Individualising treatment in breast cancer requires effective predictive biomarkers. While relatively few genomic aberrations are clinically relevant, there is a need for characterising patients across different subtypes to identify actionable alterations. METHODS: We identified genomic alterations in 49 potentially actionable genes for which drugs are available either clinically or via clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Databases, Genetic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Copy Number Variations

Share to Exome Sequencing

Share to Gene Expression Regulation, Neoplastic

Share to Gene Regulatory Networks

Share to Precision Medicine

Share to Sequence Analysis, RNA

Source

Open in PubMed Open full text

Identifiers

PMID: 34455425
DOI: 10.1038/s41416-021-01522-7
PMCID: PMC8548334

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of putative actionable alterations in clinically relevant genes in breast cancer.PMID 34455425Read ↗

Comparison of TCGA and GENIE genomic datasets for the detection of clinically actionable alterations in breast cancerSemantic proximity Read ↗

Genomic alterations in breast cancer: level of evidence for actionability according to ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)Semantic proximity Read ↗

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.Semantic proximity Read ↗

Genetic interactions reveal distinct biological and therapeutic implications in breast cancer.Semantic proximity Read ↗

Database of Genomic Biomarkers for Cancer Drugs and Clinical Targetability in Solid TumorsSemantic proximity Read ↗

The landscape of cancer genes and mutational processes in breast cancer.Semantic proximity Read ↗

From cancer genomes to oncogenic drivers, tumour dependencies and therapeutic targets.Semantic proximity Read ↗

Copy number alterations in metastatic and early breast tumours: prognostic and acquired biomarkers of resistance to CDK4/6 inhibitors.Semantic proximity Read ↗

Tumor Mutational Landscape and Its Correlation with Histopathological Characteristics in Breast CancerSemantic proximity Read ↗

Data resources for the identification and interpretation of actionable mutations by clinicians.Semantic proximity Read ↗

Signaling network assessment of mutations and copy number variations predict breast cancer subtype-specific drug targets.Semantic proximity Read ↗

Concordance of genomic alterations between primary and recurrent breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.